Roche, Gilead end feud over marketing rights for Tamiflu
Roche and Gilead Sciences ended their dispute over Tamiflu (oseltamivir) production and royalties, as they agreed on a new plan ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.